Literature DB >> 12131609

Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity.

Urban Sjöqvist1, Erik Hertervig, Ake Nilsson, Rui-Dong Duan, Ake Ost, Bernhard Tribukait, Robert Löfberg.   

Abstract

BACKGROUND AND AIMS: The hydrolysis of sphingomyelin (SM) generates key molecules regulating cell growth. Animal cancer studies support an inhibitory role for this pathway in the malignant transformation of the colonic mucosa. The activity of a specific intestinal alkaline sphingomyelinase (SMase), which hydrolyzes SM, is reduced in colorectal tumors. In this study we measured alkaline SMase activity in patients with longstanding colitis and assessed if a reduction can be used as a marker in surveillance of high risk patients.
METHODS: Alkaline SMase activity was measured in 139 colonic biopsies from 34 patients with longstanding, extensive colitis and from 11 controls. Fifteen patients had earlier diagnosis of dysplasia or DNA aneuploidy. Alkaline SMase activity was related to histologic dysplasia and DNA aneuploidy assessed by flow cytometry, patient age, and duration of disease.
RESULTS: Alkaline SMase activity was significantly lower in the patient group with and without dysplasia compared with controls (p = 0.006). In biopsies, an association was not found between alkaline SMase activity, dysplasia, or DNA ploidy. However, alkaline SMase activity decreased with age both in patients and controls (p = 0.008).
CONCLUSIONS: Reduction of alkaline SMase activity seen in colorectal cancer and adenomas is also present in patients with chronic colitis. It is not complementary to dysplasia or DNA-aneuploidy in the identification of high risk patients. The age-associated decrease of alkaline SMase activity seems to be a general phenomenon indicating premature senescence of the mucosa in longstanding colitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12131609     DOI: 10.1097/00054725-200207000-00004

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  27 in total

1.  Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity.

Authors:  Jun Wu; Ake Nilsson; Bo A G Jönsson; Hanna Stenstad; William Agace; Yajun Cheng; Rui-Dong Duan
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

2.  Crucial role of alkaline sphingomyelinase in sphingomyelin digestion: a study on enzyme knockout mice.

Authors:  Yao Zhang; Yajun Cheng; Gert H Hansen; Lise-Lotte Niels-Christiansen; Frank Koentgen; Lena Ohlsson; Ake Nilsson; Rui-Dong Duan
Journal:  J Lipid Res       Date:  2010-12-21       Impact factor: 5.922

3.  Combining aneuploidy and dysplasia for colitis' cancer risk assessment outperforms current surveillance efficiency: a meta-analysis.

Authors:  Rüdiger Meyer; Sandra Freitag-Wolf; Silke Blindow; Jürgen Büning; Jens K Habermann
Journal:  Int J Colorectal Dis       Date:  2016-10-20       Impact factor: 2.571

4.  Expression of alkaline sphingomyelinase in yeast cells and anti-inflammatory effects of the expressed enzyme in a rat colitis model.

Authors:  David Andersson; Knut Kotarsky; Jun Wu; William Agace; Rui-Dong Duan
Journal:  Dig Dis Sci       Date:  2008-11-07       Impact factor: 3.199

5.  Ceramide activates JNK to inhibit a cAMP-gated K+ conductance and Cl- secretion in intestinal epithelia.

Authors:  David E Saslowsky; Noriyuki Tanaka; Krishna P Reddy; Wayne I Lencer
Journal:  FASEB J       Date:  2008-09-26       Impact factor: 5.191

6.  The enterocyte microvillus is a vesicle-generating organelle.

Authors:  Russell E McConnell; James N Higginbotham; David A Shifrin; David L Tabb; Robert J Coffey; Matthew J Tyska
Journal:  J Cell Biol       Date:  2009-06-29       Impact factor: 10.539

7.  VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation.

Authors:  I Soo; K L Madsen; Q Tejpar; B C Sydora; R Sherbaniuk; B Cinque; L Di Marzio; M Grazia Cifone; C Desimone; R N Fedorak
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

8.  Functional studies of human intestinal alkaline sphingomyelinase by deglycosylation and mutagenesis.

Authors:  Jun Wu; Gert H Hansen; Ake Nilsson; Rui-Dong Duan
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

9.  PPARα-dependent exacerbation of experimental colitis by the hypolipidemic drug fenofibrate.

Authors:  Yunpeng Qi; Changtao Jiang; Naoki Tanaka; Kristopher W Krausz; Chad N Brocker; Zhong-Ze Fang; Bryce X Bredell; Yatrik M Shah; Frank J Gonzalez
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-17       Impact factor: 4.052

Review 10.  Sphingolipids in colon cancer.

Authors:  Mónica García-Barros; Nicolas Coant; Jean-Philip Truman; Ashley J Snider; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.